​

Mirum Pharmaceuticals (MIRM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Mirum Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$336.89M

Latest Revenue (Q)

$133.01M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Mirum Pharmaceuticals Revenue by Period

Mirum Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$336.89M80.76%
2023-12-31$186.37M141.85%
2022-12-31$77.06M302.66%
2021-12-31$19.14M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Mirum Pharmaceuticals generated $336.89M in revenue during NA 2024, up 80.76% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30$133.01M4.09%
2025-06-30$127.78M14.52%
2025-03-31$111.58M12.24%
2024-12-31$99.41M10.00%
2024-09-30$90.38M16.05%
2024-06-30$77.88M12.50%
2024-03-31$69.22M-0.48%
2023-12-31$69.55M45.74%
2023-09-30$47.73M27.28%
2023-06-30$37.50M18.67%
2023-03-31$31.60M13.23%
2022-12-31$27.91M48.59%
2022-09-30$18.78M7.41%
2022-06-30$17.48M35.62%
2022-03-31$12.89M310.83%
2021-12-31$3.14M-37.24%
2021-09-30$5.00M-54.55%
2021-06-30$11.00M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

Mirum Pharmaceuticals generated $133.01M in revenue during Q3 2025, up 4.09% compared to the previous quarter, and up 170.80% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue Breakdown

Mirum Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Product$336.41M$178.87M$75.06M$3.14M
License and Other Revenue$479.00K---
License Revenue-$7.50M--
License--$2.00M$16.00M

Mirum Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (99.86%), and License and Other Revenue (0.14%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Product$133.01M$127.78M$111.58M$177.19M$90.30M$68.92M$69.55M$47.73M$32.50M$29.10M$27.91M$18.78M$17.48M$10.89M
License and Other Revenue---$99.00K$75.00K$305.00K--------
License Revenue-------$7.50M------
License--------$5.00M$2.50M---$2.00M

Mirum Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Product (100.00%).

Mirum Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23
Rest of the World$62.24M-
UNITED STATES$274.17M$146.70M
Rest of World-$32.17M

Mirum Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (81.50%), and Rest of the World (18.50%).

Quarterly Revenue by Country

CountrySep 25Jun 25Mar 25Dec 24Sep 24Mar 24
UNITED STATES$103.71M$95.53M$86.92M$144.16M$73.91M$56.11M
Rest Of World$29.30M$32.25M$24.66M$16.40M$12.81M-

Mirum Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (77.97%), and Rest Of World (22.03%).

Mirum Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ACADACADIA Pharmaceuticals$957.80M$278.63M
TLXTelix Pharmaceuticals$783.21M$7.41M
RAREUltragenyx Pharmaceutical$560.23M$159.93M
ADMAADMA Biologics$426.45M$134.22M
MIRMMirum Pharmaceuticals$336.89M$133.01M
TVTXTravere Therapeutics$233.18M$164.86M
LGNDLigand Pharmaceuticals$167.13M$115.46M
PRAXPraxis Precision Medicines$8.55M-
SLNOSoleno Therapeutics-$66.02M
DYNDyne Therapeutics--
BLTEBelite Bio--

MIRM Revenue FAQ

What is Mirum Pharmaceuticals’s yearly revenue?

Mirum Pharmaceuticals's yearly revenue for 2024 was $336.89M, representing an increase of 80.76% compared to 2023. The company's yearly revenue for 2023 was $186.37M, representing an increase of 141.85% compared to 2022. MIRM's yearly revenue for 2022 was $77.06M, representing an increase of 302.66% compared to 2021.

What is Mirum Pharmaceuticals’s quarterly revenue?

Mirum Pharmaceuticals's quarterly revenue for Q3 2025 was $133.01M, a 4.09% increase from the previous quarter (Q2 2025), and a 47.17% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $127.78M, a 14.52% increase from the previous quarter (Q1 2025), and a 64.09% increase year-over-year (Q2 2024). MIRM's quarterly revenue for Q1 2025 was $111.58M, a 12.24% increase from the previous quarter (Q4 2024), and a 61.20% increase year-over-year (Q1 2024).

What is Mirum Pharmaceuticals’s revenue growth rate?

Mirum Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 337.16%, and for the last 5 years (2020-2024) was 0%.

What are Mirum Pharmaceuticals’s revenue streams?

Mirum Pharmaceuticals's revenue streams in c 24 are Product, and License and Other Revenue. Product generated $336.41M in revenue, accounting 99.86% of the company's total revenue, up 88.07% year-over-year. License and Other Revenue generated $479K in revenue, accounting 0.14% of the company's total revenue

What is Mirum Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Mirum Pharmaceuticals was Product. This segment made a revenue of $336.41M, representing 99.86% of the company's total revenue.